Cargando…
Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review
We reviewed technical parameters, acquisition protocols and adverse reactions (ARs) for contrast-enhanced spectral mammography (CESM). A systematic search in databases, including MEDLINE/EMBASE, was performed to extract publication year, country of origin, study design; patients; mammography unit/ve...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677840/ https://www.ncbi.nlm.nih.gov/pubmed/31376021 http://dx.doi.org/10.1186/s13244-019-0756-0 |
_version_ | 1783440967598080000 |
---|---|
author | Zanardo, Moreno Cozzi, Andrea Trimboli, Rubina Manuela Labaj, Olgerta Monti, Caterina Beatrice Schiaffino, Simone Carbonaro, Luca Alessandro Sardanelli, Francesco |
author_facet | Zanardo, Moreno Cozzi, Andrea Trimboli, Rubina Manuela Labaj, Olgerta Monti, Caterina Beatrice Schiaffino, Simone Carbonaro, Luca Alessandro Sardanelli, Francesco |
author_sort | Zanardo, Moreno |
collection | PubMed |
description | We reviewed technical parameters, acquisition protocols and adverse reactions (ARs) for contrast-enhanced spectral mammography (CESM). A systematic search in databases, including MEDLINE/EMBASE, was performed to extract publication year, country of origin, study design; patients; mammography unit/vendor, radiation dose, low-/high-energy tube voltage; contrast molecule, concentration and dose; injection modality, ARs and acquisition delay; order of views; examination time. Of 120 retrieved articles, 84 were included from 22 countries (September 2003–January 2019), totalling 14012 patients. Design was prospective in 44/84 studies (52%); in 70/84 articles (83%), a General Electric unit with factory-set kVp was used. Per-view average glandular dose, reported in 12/84 studies (14%), ranged 0.43–2.65 mGy. Contrast type/concentration was reported in 79/84 studies (94%), with Iohexol 350 mgI/mL mostly used (25/79, 32%), dose and flow rate in 72/84 (86%), with 1.5 mL/kg dose at 3 mL/s in 62/72 studies (86%). Injection was described in 69/84 articles (82%), automated in 59/69 (85%), manual in 10/69 (15%) and flush in 35/84 (42%), with 10–30 mL dose in 19/35 (54%). An examination time < 10 min was reported in 65/84 studies (77%), 120 s acquisition delay in 65/84 (77%) and order of views in 42/84 (50%) studies, beginning with the craniocaudal view of the non-suspected breast in 7/42 (17%). Thirty ARs were reported by 14/84 (17%) studies (26 mild, 3 moderate, 1 severe non-fatal) with a pooled rate of 0.82% (fixed-effect model). Only half of CESM studies were prospective; factory-set kVp, contrast 1.5 mL/kg at 3 mL/s and 120 s acquisition delay were mostly used; only 1 severe AR was reported. CESM protocol standardisation is advisable. |
format | Online Article Text |
id | pubmed-6677840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-66778402019-08-16 Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review Zanardo, Moreno Cozzi, Andrea Trimboli, Rubina Manuela Labaj, Olgerta Monti, Caterina Beatrice Schiaffino, Simone Carbonaro, Luca Alessandro Sardanelli, Francesco Insights Imaging Critical Review We reviewed technical parameters, acquisition protocols and adverse reactions (ARs) for contrast-enhanced spectral mammography (CESM). A systematic search in databases, including MEDLINE/EMBASE, was performed to extract publication year, country of origin, study design; patients; mammography unit/vendor, radiation dose, low-/high-energy tube voltage; contrast molecule, concentration and dose; injection modality, ARs and acquisition delay; order of views; examination time. Of 120 retrieved articles, 84 were included from 22 countries (September 2003–January 2019), totalling 14012 patients. Design was prospective in 44/84 studies (52%); in 70/84 articles (83%), a General Electric unit with factory-set kVp was used. Per-view average glandular dose, reported in 12/84 studies (14%), ranged 0.43–2.65 mGy. Contrast type/concentration was reported in 79/84 studies (94%), with Iohexol 350 mgI/mL mostly used (25/79, 32%), dose and flow rate in 72/84 (86%), with 1.5 mL/kg dose at 3 mL/s in 62/72 studies (86%). Injection was described in 69/84 articles (82%), automated in 59/69 (85%), manual in 10/69 (15%) and flush in 35/84 (42%), with 10–30 mL dose in 19/35 (54%). An examination time < 10 min was reported in 65/84 studies (77%), 120 s acquisition delay in 65/84 (77%) and order of views in 42/84 (50%) studies, beginning with the craniocaudal view of the non-suspected breast in 7/42 (17%). Thirty ARs were reported by 14/84 (17%) studies (26 mild, 3 moderate, 1 severe non-fatal) with a pooled rate of 0.82% (fixed-effect model). Only half of CESM studies were prospective; factory-set kVp, contrast 1.5 mL/kg at 3 mL/s and 120 s acquisition delay were mostly used; only 1 severe AR was reported. CESM protocol standardisation is advisable. Springer Berlin Heidelberg 2019-08-02 /pmc/articles/PMC6677840/ /pubmed/31376021 http://dx.doi.org/10.1186/s13244-019-0756-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Critical Review Zanardo, Moreno Cozzi, Andrea Trimboli, Rubina Manuela Labaj, Olgerta Monti, Caterina Beatrice Schiaffino, Simone Carbonaro, Luca Alessandro Sardanelli, Francesco Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review |
title | Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review |
title_full | Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review |
title_fullStr | Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review |
title_full_unstemmed | Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review |
title_short | Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review |
title_sort | technique, protocols and adverse reactions for contrast-enhanced spectral mammography (cesm): a systematic review |
topic | Critical Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677840/ https://www.ncbi.nlm.nih.gov/pubmed/31376021 http://dx.doi.org/10.1186/s13244-019-0756-0 |
work_keys_str_mv | AT zanardomoreno techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview AT cozziandrea techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview AT trimbolirubinamanuela techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview AT labajolgerta techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview AT monticaterinabeatrice techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview AT schiaffinosimone techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview AT carbonarolucaalessandro techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview AT sardanellifrancesco techniqueprotocolsandadversereactionsforcontrastenhancedspectralmammographycesmasystematicreview |